SECURON Solution for injection Ref.[7144] Active ingredients: Verapamil

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2024  Publisher: Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom

Product name and form

Securon IV.

Pharmaceutical Form

Aqueous solution for intravenous injection.

Qualitative and quantitative composition

Verapamil Hydrochloride BP 2.5 mg/ml.

Active Ingredient Description
Verapamil

Verapamil inhibits the transmembrane influx of calcium ions into the heart and vascular smooth muscle cell. The myocardial oxygen demand is lowered directly as a result of the effect on the energy consuming metabolic processes of the myocardial cell and indirectly due to a reduction of the afterload. Due to its effect on coronary vascular smooth muscle, verapamil enhances myocardial blood flow, even in postโ€stenotic areas, and relieves coronary spasms. These properties contribute to the antiโ€ischaemic and antianginal efficacy of verapamil in all types of coronary artery disease.

List of Excipients

Water for injections
Sodium chloride (8.5 mg/ml)
Hydrochloric acid 10% as pH adjuster

Pack sizes and marketing

2 ml glass ampoule (hydrolytic type 1) containing 5 mg verapamil.

Pack size: 5 ร— 2 ml ampoules.

Marketing authorization holder

Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom

Marketing authorization dates and numbers

PL 46302/0026

17 June 2003

Drugs

Drug Countries
SECURON Malta, United Kingdom

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.